<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Quesenberry PJ</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>27575</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4553260</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4</volume><pubmed_abstract>The NIH Extracellular RNA Communication Program's initiative on clinical utility of extracellular RNAs and therapeutic agents and developing scalable technologies is reviewed here. Background information and details of the projects are presented. The work has focused on modulation of target cell fate by extracellular vesicles (EVs) and RNA. Work on plant-derived vesicles is of intense interest, and non-mammalian sources of vesicles may represent a very promising source for different therapeutic approaches. Retro-viral-like particles are intriguing. Clearly, EVs share pathways with the assembly machinery of several other viruses, including human endogenous retrovirals (HERVs), and this convergence may explain the observation of viral-like particles containing viral proteins and nucleic acid</pubmed_abstract><journal>Journal of extracellular vesicles</journal><pubmed_title>Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium.</pubmed_title><pmcid>PMC4553260</pmcid><funding_grant_id>P50 CA095103</funding_grant_id><funding_grant_id>T32 HL116249</funding_grant_id><funding_grant_id>UH2 TR000880</funding_grant_id><funding_grant_id>P30 DK058404</funding_grant_id><funding_grant_id>UH3 TR000901</funding_grant_id><funding_grant_id>U19 CA179514</funding_grant_id><funding_grant_id>U19 CA179563</funding_grant_id><funding_grant_id>UH3 TR000918</funding_grant_id><funding_grant_id>UH3 TR000928</funding_grant_id><funding_grant_id>R01 HL122547</funding_grant_id><funding_grant_id>UH2 TR000901</funding_grant_id><funding_grant_id>UH2 TR000928</funding_grant_id><funding_grant_id>R01 CA163563</funding_grant_id><funding_grant_id>UH2TR000875</funding_grant_id><funding_grant_id>UH2 TR000875</funding_grant_id><funding_grant_id>UH3 TR000880</funding_grant_id><pubmed_authors>Danielson K</pubmed_authors><pubmed_authors>Balaj L</pubmed_authors><pubmed_authors>Coffey RJ</pubmed_authors><pubmed_authors>Das S</pubmed_authors><pubmed_authors>Zhang HG</pubmed_authors><pubmed_authors>Chen CC</pubmed_authors><pubmed_authors>Aliotta J</pubmed_authors><pubmed_authors>Wen S</pubmed_authors><pubmed_authors>Abdel-Mageed AB</pubmed_authors><pubmed_authors>Chatterjee D</pubmed_authors><pubmed_authors>Quesenberry PJ</pubmed_authors><pubmed_authors>Tetta C</pubmed_authors><pubmed_authors>Franklin J</pubmed_authors><pubmed_authors>Dooner M</pubmed_authors><pubmed_authors>Pusic AD</pubmed_authors><pubmed_authors>Subramanya V</pubmed_authors><pubmed_authors>Pusic KM</pubmed_authors><pubmed_authors>Camussi G</pubmed_authors><pubmed_authors>Goldberg L</pubmed_authors><pubmed_authors>Ghiran I</pubmed_authors><pubmed_authors>Kraig RP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium.</name><description>The NIH Extracellular RNA Communication Program's initiative on clinical utility of extracellular RNAs and therapeutic agents and developing scalable technologies is reviewed here. Background information and details of the projects are presented. The work has focused on modulation of target cell fate by extracellular vesicles (EVs) and RNA. Work on plant-derived vesicles is of intense interest, and non-mammalian sources of vesicles may represent a very promising source for different therapeutic approaches. Retro-viral-like particles are intriguing. Clearly, EVs share pathways with the assembly machinery of several other viruses, including human endogenous retrovirals (HERVs), and this convergence may explain the observation of viral-like particles containing viral proteins and nucleic acid</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2025-04-26T21:55:27.886Z</modification><creation>2019-03-27T01:57:30Z</creation></dates><accession>S-EPMC4553260</accession><cross_references><pubmed>26320942</pubmed><doi>10.3402/jev.v4.27575</doi></cross_references></HashMap>